Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

With its International Headquarters in Zug, Switzerland, Alnylam has become a key part of the Swiss biotech environment.

The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) has received an average rating of “Buy” from the nine research firms ...

The United States market has shown robust performance recently, climbing 3.0% in the last week and achieving a 25% increase over the past year, with earnings expected to grow by 15% annually. In this ...

Dry Age-Related Macular Degeneration Pipeline Report Introduction 2. Dry Age-Related Macular Degeneration Pipeline Report Executive Summary ...